INSIGHTS ON DRUG DEVELOPMENT

• Accelerating Clinical Development: Modern Tools In Process Chemistry

  Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.

• The Power Couple: CRISPR And Oligonucleotides

  Drug design using CRISPR depends on long guide RNA (gRNA) sequences. Find out how this match between long oligos and CRISPR works.

• 384-Well Microplate Time Resolved Fluorescence (TRF) Immunoassay

  Examine how innovative sandwich ELISAs in a 384-well format can be utilized with a sensitive reader for high-throughput screening to quantify Human IgG and IFN gamma.

• Advantages Of Spray-Dried Mannitol In Roll Compaction

  Pharmaceutical excipients like mannitol enhance formulation stability, flowability, and compressibility, which are crucial for robust tablets. Read how these properties improve patient compliance.

• Analysis Of Drug-Excipient Incompatibility In Discovery And Formulation Development

  3/7/2024

  We analyze drug-excipient incompatibility using a microcalorimeter system equipped with a multi-sample cell capable of simultaneously measuring highly sensitive heat flow data from up to three samples.

• Nanomedicine Modalities Find Path To Clinic Through Analytics

  5/16/2025

  Lipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.

• Lightning-Link^® Conjugation Kits: Consistent Performance On A Broad Scale

  9/26/2024

  Learn about labeling technology offering a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results.

• 3 Key Considerations In Gene Therapy Manufacturing

  7/15/2025

  Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.

• Innovative Octet® Biolayer Interferometry (BLI) Approach For Non-Disruptive And Fast AAV Capsid Ratio Determination In Complex Biological Matrices

  9/27/2024

  Learn about a biosensor that was designed to provide the rapid, real-time, high-throughput measurement of AAV capsid titer in samples throughout the AAV workflow.